Who is sponsoring NCT01286493?

NCT01286493 is sponsored by Queen Saovabha Memorial Institute.

What condition does NCT01286493 study?

NCT01286493 studies HIV, Rabies.

What drugs are being tested in NCT01286493?

Interventions: rabies vaccines on day 0 and 3.

What is the status of NCT01286493?

NCT01286493 is currently COMPLETED.

Last reviewed 2015-10-19 · How we verify

Immune Response After Booster Vaccination in HIV - Infected Patients Who Ever Received Rabies Primary Vaccination

NCT01286493 NA COMPLETED Results posted

Booster rabies vaccination in HIV - infected patients who have ever received rabies primary vaccination could improve their immune response to this kind of vaccine.

Details

Lead sponsor	Queen Saovabha Memorial Institute
Phase	NA
Status	COMPLETED
Enrolment	33
Start date	2011-02
Completion	2013-12

Conditions

HIV
Rabies

Interventions

rabies vaccines on day 0 and 3

Primary outcomes

Rabies Neutralizing Antibody Titers — Day 360
Rabies Neutralizing Antibody titers(RNab)of HIV-infected patients who receive booster rabies vaccination would be measured by Rapid Fluorescent Focus Inhibition Test(RFFIT) method at day 0, 7, 14, 28, 90,180 and 360. RNab level above 0.5 IU/ml indicate acceptable protective antibody response. for 7 times in 1 year.

Countries

Thailand